Literature DB >> 17206716

Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn's disease.

Luciane C Coppi1, Sara M Thomazzi, Maria Lourdes S de Ayrizono, Claudio S R Coy, W Joao J Fagundes, Juvenal R N Goes, Gilberto C Franchi, Alexandre E Nowill, Ciro G Montes, Edson Antunes, Jose Geraldo P Ferraz.   

Abstract

BACKGROUND: Eosinophils have been identified in tissues from patients with Crohn's disease (CD) and ulcerative colitis (UC) but whether they contribute to IBD pathogenesis is unknown. This study aimed to investigate the functional activity and morphological aspects of peripheral-blood eosinophils from IBD patients compared to those from healthy volunteers (HVs).
METHODS: Eosinophils from HVs and CD and UC patients were purified using a Percoll gradient and then a immunomagnetic cell separator. Functional activity in inactivated and previously activated cells was investigated by measuring adhesion to fibronectin and chemotaxis to fMLP, and degranulation was measured by release of eosinophil peroxidase (EPO). Cell morphology was investigated using electron microscopy.
RESULTS: Eosinophil adhesion to human fibronectin in both inactivated and PAF-stimulated and PMA-stimulated eosinophils was markedly higher in patients with CD than in either patients with UC or HVs. Similarly, the chemotactic response was markedly higher in eosinophils isolated from CD patients than in those isolated from UC patients or HVs. Baseline EPO release was higher in eosinophils isolated from UC patients than in those isolated from HVs or CD patients. Stimulation with fMLP or PMA did not further increase EPO release in cells from UC or CD patients. Comparable expression of MAC- 1 and VLA-4 adhesion molecules was observed on the surfaces of eosinophils from all groups, and an greater number of granules was noted in the eosinophils from UC patients than in those from CD patients.
CONCLUSIONS: Our results indicate that peripheral-blood eosinophils are potentially primed and activated in IBD patients. Whether the differences in the morphology and functional responses of eosinophil from UC and CD patients reflect differences in disease phenotype remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206716     DOI: 10.1002/ibd.20018

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  10 in total

1.  Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.

Authors:  Benjamin Click; Alyce M Anderson; Ioannis E Koutroubakis; Claudia Ramos Rivers; Dmitriy Babichenko; Jorge D Machicado; Douglas J Hartman; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Arthur Barrie; Sally E Wenzel; Miguel Regueiro; David G Binion
Journal:  Am J Gastroenterol       Date:  2017-11-07       Impact factor: 10.864

2.  Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.

Authors:  K Takahashi; H Imaeda; T Fujimoto; H Ban; S Bamba; T Tsujikawa; M Sasaki; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

3.  Neutrophil and Eosinophil Granule Proteins as Potential Biomarkers of Assessing Disease Activity and Severity in Patients With Ulcerative Colitis.

Authors:  Zhiyan Li; Yan Long; Mingjian Bai; Junxia Li; Zhenru Feng
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352

4.  Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.

Authors:  Kristin Blom; Jenny Rubin; Jonas Halfvarson; Leif Törkvist; Anders Rönnblom; Per Sangfelt; Mikael Lördal; Ulla-Britt Jönsson; Urban Sjöqvist; Lena Douhan Håkansson; Per Venge; Marie Carlson
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

5.  Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease.

Authors:  Balázs Radnai; Eva M Sturm; Angela Stančić; Katharina Jandl; Sandra Labocha; Nerea Ferreirós; Magdalena Grill; Carina Hasenoehrl; Gregor Gorkiewicz; Gunther Marsche; Ákos Heinemann; Christoph Högenauer; Rudolf Schicho
Journal:  J Crohns Colitis       Date:  2016-02-29       Impact factor: 9.071

6.  Opposing roles of prostaglandin D2 receptors in ulcerative colitis.

Authors:  Eva M Sturm; Balazs Radnai; Katharina Jandl; Angela Stančić; Gerald P Parzmair; Christoph Högenauer; Patrizia Kump; Heimo Wenzl; Wolfgang Petritsch; Thomas R Pieber; Rufina Schuligoi; Gunther Marsche; Nerea Ferreirós; Akos Heinemann; Rudolf Schicho
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

Review 7.  Intestinal eosinophils, homeostasis and response to bacterial intrusion.

Authors:  Alessandra Gurtner; Ignacio Gonzalez-Perez; Isabelle C Arnold
Journal:  Semin Immunopathol       Date:  2021-04-30       Impact factor: 9.623

Review 8.  Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?

Authors:  Inge Jacobs; Matthias Ceulemans; Lucas Wauters; Christine Breynaert; Séverine Vermeire; Bram Verstockt; Tim Vanuytsel
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

Review 9.  Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa.

Authors:  Marina García-Miguel; M Julieta González; Rodrigo Quera; Marcela A Hermoso
Journal:  Biomed Res Int       Date:  2012-12-04       Impact factor: 3.411

10.  Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD.

Authors:  Katarzyna Neubauer; Malgorzata Matusiewicz; Iwona Bednarz-Misa; Sabina Gorska; Andrzej Gamian; Malgorzata Krzystek-Korpacka
Journal:  Gastroenterol Res Pract       Date:  2018-07-29       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.